Grais Linda has filed 3 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 15000 shares of Corvus Pharmaceuticals, Inc. ($CRVS) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | Grais Linda | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 75,152,514 | 9999.99% | 0.02% |
| June 13, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | Grais Linda | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 49,038,582 | 9999.99% | 0.03% |
| Jan. 30, 2024 | Oruka Therapeutics, Inc. | $ORKA | Grais Linda | Director | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |